ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618332; 2) Community: the network communities that were significantly associated with the response to NSC 618332; 3) Molecule: the relationships between components within communities and NSC 618332; 4) MDR: the compounds that were significantly associated with the NSC 618332.

NSC Compound Enrichment Correlation
NSC 703329 Null 0.0342636096654271 0.35640296
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.0342636096654271 0.33261983
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0342636096654271 0.21625197
NSC 737231 Null 0.0342636096654271 0.30447009
NSC 758881 Orlistat (USAN) 0.0342636096654271 0.38148521
NSC 13318 Null 0.0342636096654276 0.29713836
NSC 179187 Salasdine 0.0342636096654276 0.13708234
NSC 274553 Null 0.0342636096654276 0.19757769
NSC 29443 Null 0.0342636096654276 0.16877868
NSC 299117 24-Norchola-20,22-diene-4-carboxaldehyde, 3,12-bis(acetyloxy)-14,15:21,23-diepoxy-1,7,19-trihydroxy-4,8-dimethyl-11-oxo-, cyclic 4,19-(acetyl acetal), [1.alpha.,3.alpha.,4.beta.(S),5.alpha.,7.alpha., 0.0342636096654276 0.17208847
Total:47  Current:34    [First] [Prev] [Next] [Last]